Kyowa Kirin Co., Ltd.
OTC: KYKOF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Abdul Hafeez Mullick
- Employees
- 5,669
- Headquarters
- Tokyo, Japan
- IPO year
- 2012
- Market cap
- $7.6B
- Website
- https://www.kyowakirin.com
Loading KYKOF…
Loading profile data…Frequently asked questions about KYKOF
What does Kyowa Kirin Co., Ltd. (KYKOF) do?
Kyowa Kirin Co., Ltd. is a global pharmaceutical company engaged in the development, manufacturing, and commercialization of medicines, with a primary focus on therapeutic areas including oncology, nephrology, central nervous system disorders, and immunological conditions. The company's extensive pharmaceutical portfolio encompasses solutions ac...
Where does KYKOF trade?
Kyowa Kirin Co., Ltd. (KYKOF) trades on the Other OTC.
What sector is KYKOF in?
Kyowa Kirin Co., Ltd. (KYKOF) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Kyowa Kirin Co., Ltd.?
Abdul Hafeez Mullick is the chief executive officer of Kyowa Kirin Co., Ltd. (KYKOF).
Where is Kyowa Kirin Co., Ltd. headquartered?
Kyowa Kirin Co., Ltd. is headquartered in Japan.
Does KYKOF pay a dividend?
Yes — Kyowa Kirin Co., Ltd. (KYKOF) paid a trailing twelve-month dividend of USD 0.41 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did KYKOF go public?
Kyowa Kirin Co., Ltd. (KYKOF) completed its initial public offering in 2012.